慢性阻塞性肺疾病急性加重患者肺栓塞患病率:系统评价与Meta分析
该系统评价与Meta分析检索MEDLINE、Cochrane对照试验中心注册库和Embase,纳入16项研究共4093例AECOPD患者,评估肺栓塞患病率。合并肺栓塞患病率为12%(95%CI 9–16%),异质性显著(I2=94.8%)。合并肺栓塞患者死亡率高于无肺栓塞者(OR 5.30,95%CI 2.48–11.30,P<0.001)。作者认为,这提示急需制定经过验证的诊断策略以识别AECOPD患者的肺栓塞。
要点
- AECOPD患者中肺栓塞的合并患病率为12%(95%CI 9–16%),来自16项研究、4093例患者。
- 合并肺栓塞的AECOPD患者死亡率高于无肺栓塞者(OR 5.30,95%CI 2.48–11.30,P<0.001)。
- 研究间异质性显著(I2=94.8%),患病率估计需结合具体临床情境解读。
- 作者认为,急需制定经过验证的诊断策略以在AECOPD患者中识别肺栓塞。
适用人群与场景
- 年龄≥18岁的慢性阻塞性肺疾病急性加重(AECOPD)患者。
- 纳入标准为前瞻性研究或预先规定肺栓塞检查方案的横断面研究,且报告肺栓塞或静脉血栓栓塞症患病率。
研究设计与关键结果
- 研究类型:系统评价与Meta分析,检索MEDLINE、Cochrane对照试验中心注册库和Embase,方案在PROSPERO注册(CRD42021230481)。
- 纳入16项研究,共4093例AECOPD患者;采用随机效应模型进行所有分析。
- 主要结局:AECOPD患者中肺栓塞患病率为12%(95%CI 9–16%),异质性显著(I2=94.8%)。
- 合并肺栓塞患者死亡率高于无肺栓塞者(OR 5.30,95%CI 2.48–11.30,P<0.001)。
证据类型、等级与局限
- 证据类型:系统评价与Meta分析,纳入前瞻性研究或预先规定肺栓塞检查方案的横断面研究。
- 异质性显著(I2=94.8%)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,AECOPD患者中肺栓塞患病率为12%且合并肺栓塞者死亡率更高,这提示急需制定经过验证的诊断策略以识别AECOPD患者的肺栓塞。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
STUDY OBJECTIVE: Identification of pulmonary embolism (PE) in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) carries significant therapeutic implications. We aimed to investigate the prevalence of PE in patients with AECOPD.
METHODS: We searched MEDLINE, the Cochrane Central Register of Controlled Trials, and Embase. We registered the protocol at the PROSPERO (CRD42021230481). Two authors independently evaluated whether titles and abstracts met the eligibility criteria, which were as follows: (1), prospective study or cross-sectional study in case the protocol for workup of PE was specified in advance, (2) patients with AECOPD aged ≥ 18 years, and (3) investigated the prevalence of PE or venous thromboembolism (VTE). Two authors independently extracted the selected patient and study characteristics and outcomes. We presented the results of all analyses with the use of random-effects models. The primary outcome was the prevalence of PE.
RESULTS: We included 16 studies (N = 4093 patients) in this meta-analysis. The prevalence of PE in patients with AECOPD was 12% [95% confidence interval (CI), 9 to 16%]. Substantial heterogeneity was observed (I2 = 94.8%). The pooled mortality was higher in patients with PE than those without (odds ratio 5.30, 95%CI: 2.48-11.30, p-value < 0.001).
CONCLUSION: In this meta-analysis, the prevalence of PE in patients with AECOPD was 12% and the mortality of patients with PE was higher than those without. This suggests an acute necessity to develop validated diagnostic strategies for identifying PE in patients with AECOPD.
参考来源
- Sato R, Hasegawa D, Nishida K, et al. Prevalence of pulmonary embolism in patients with acute exacerbations of COPD: A systematic review and meta-analysis. Am J Emerg Med. 2021. PMID: 34879475. doi:10.1016/j.ajem.2021.09.041
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。